Orazymbet Se 1

1. Determination of the Toxicity and Sensitizing effect of a Therapeutic Probiotic agent against Intestinal and Concomitant human infections
2. Development of Technology for the production of finished forms of Medicinal probiotics
3. Selection of medicinal plants suppressing growth of multidrug-resistant strain of tuberculosis causative agent
4. Active Pharmaceutical Substance Production Technology using Lactobacillus fermentum and Lactobacillus cellobiosus for the treatment of Intestinal Infections
5. Technology for the production of Lyophilizate of an association of Lactic acid bacteria included in the Medicinal product AS-Probionorm
1